Jaceosidin induces apoptosis and inhibits migration in AGS gastric cancer cells by regulating ROS-mediated signaling pathways

References

• Yusefi AR, Bagheri Lankarani K, Bastani P, et al. Risk factors for gastric cancer: a systematic review. Asian Pac J Cancer Prev. 2018;19(3):591–603.
   PubMedGoogle Scholar
• Gao JP, Xu W, Liu WT, et al. Tumor heterogeneity of gastric cancer: from the perspective of tumor-initiating cell. World J Gastroenterol. 2018;24(24):2567–2581.
   PubMed Web of Science ®Google Scholar
• Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012.
   PubMed Web of Science ®Google Scholar
• Sexton RE, Al Hallak MN, Diab M, et al. Gastric cancer: a comprehensive review of current and future treatment strategies. Cancer Metastasis Rev. 2020;39(4):1179–1203.
   PubMed Web of Science ®Google Scholar
• Tan Z. Recent advances in the surgical treatment of advanced gastric cancer: a review. Med Sci Monit. 2019;25:3537–3541.
   PubMed Web of Science ®Google Scholar
• Yang YH, Mao JW, Tan XL. Research progress on the source: production, and anti-cancer mechanisms of paclitaxel. Chin J Nat Med. 2020;18(12):890–897.
   PubMed Web of Science ®Google Scholar
• Luo H, Vong CT, Chen H, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14:48.
   PubMed Web of Science ®Google Scholar
• Tang SM, Deng XT, Zhou J, et al. Pharmacological basis and new insights of quercetin action in respect to its anti-cancer effects. Biomed Pharmacother. 2020;121:109604.
   PubMed Web of Science ®Google Scholar
• Slika H, Mansour H, Wehbe N, et al. Therapeutic potential of flavonoids in cancer: ROS-mediated mechanisms. Biomed Pharmacother. 2022;146:112442.
   PubMed Web of Science ®Google Scholar
• Dewanjee S, Chakraborty P, Bhattacharya H, et al. Recent advances in flavonoid-based nanocarriers as an emerging drug delivery approach for cancer chemotherapy. Drug Discov Today. 2023;28(1):103409.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Gu K, Zhou F. Dietary flavonoid intake and cancer mortality: a population-based cohort study. Nutrients. 2023;15(4):976.
   PubMed Web of Science ®Google Scholar
• Hazafa A, Rehman KU, Jahan N, et al. The role of polyphenol (flavonoids) compounds in the treatment of cancer cells. Nutr Cancer. 2020;72(3):386–397.
   PubMed Web of Science ®Google Scholar
• Jeong, MA, Lee, KW, Yoon, DY, et al. Jaceosidin, a pharmacologically active flavone derived from Artemisia argyi, inhibits phorbol-ester-induced upregulation of COX-2 and MMP-9 by blocking phosphorylation of ERK-1 and -2 in cultured human mammary epithelial cells. Ann N Y Acad Sci 2007;1095:458–466.
   PubMed Web of Science ®Google Scholar
• Lee H, Jang D, Jeon J, et al. Seomae mugwort and jaceosidin attenuate osteoarthritic cartilage damage by blocking IκB degradation in mice. J Cell Mol Med. 2020;24(14):8126–8137.
   PubMed Web of Science ®Google Scholar
• Yuan H, Lu X, Ma Q, et al. Flavonoids from Artemisia sacrorum Ledeb. and their cytotoxic activities against human cancer cell lines. Exp Ther Med. 2016;12(3):1873–1878.
   PubMed Web of Science ®Google Scholar
• Park E, Hong K, Kwon BM, et al. Jaceosidin ameliorates insulin resistance and kidney dysfunction by enhancing insulin receptor signaling and the antioxidant defense system in type 2 diabetic mice. J Med Food. 2020;23(10):1083–1092.
   PubMed Web of Science ®Google Scholar
• Han HY, Kim HJ, Jeong SH, et al. The flavonoid jaceosidin from artemisia princeps induces apoptotic cell death and inhibits the Akt pathway in oral cancer cells. Evid Based Complement Alternat Med. 2018;2018:5765047.
   PubMed Web of Science ®Google Scholar
• Lv W, Sheng X, Chen T, et al. Jaceosidin induces apoptosis in human ovary cancer cells through mitochondrial pathway. J Biomed Biotechnol. 2008;2008:394802.
   PubMed Web of Science ®Google Scholar
• Ojulari OV, Chae JB, Lee SG, et al. Apoptotic effect of jaceosidin on MCF-7 human breast cancer cells through modulation of ERK and p38 MAPK pathways. Nat Prod Res. 2021;35(24):6049–6053.
   PubMed Web of Science ®Google Scholar
• Kerr JF. History of the events leading to the formulation of the apoptosis concept. Toxicology. 2002;181-182:471–474.
   PubMed Web of Science ®Google Scholar
• Moloney JN, Cotter TG. ROS signalling in the biology of cancer. Semin Cell Dev Biol. 2018;80:50–64.
   PubMed Web of Science ®Google Scholar
• Jeong SY, Seol DW. The role of mitochondria in apoptosis. BMB Rep. 2008;41(1):11–22.
   PubMed Web of Science ®Google Scholar
• Fan J, Ren D, Wang J, et al. Bruceine D induces lung cancer cell apoptosis and autophagy via the ROS/MAPK signaling pathway in vitro and in vivo. Cell Death Dis. 2020;11(2):126.
   PubMed Web of Science ®Google Scholar
• Zou S, Tong Q, Liu B, et al. Targeting STAT3 in Cancer Immunotherapy. Mol Cancer. 2020;19(1):145.
   PubMed Web of Science ®Google Scholar
• Dolcet X, Llobet D, Pallares J, et al. NF-kB in development and progression of human cancer. Virchows Arch. 2005;446(5):475–482.
   PubMed Web of Science ®Google Scholar
• Radha G, Raghavan SC. BCL2: a promising cancer therapeutic target. Biochim Biophys Acta Rev Cancer. 2017;1868(1):309–314.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li M, Wang X, et al. Caspase cleavage of cytochrome c1 disrupts mitochondrial function and enhances cytochrome c release. Cell Res. 2012;22(1):127–141.
   PubMed Web of Science ®Google Scholar
• Büki A, Okonkwo DO, Wang KK, et al. Cytochrome c release and caspase activation in traumatic axonal injury. J. Neurosci. 2000;20(8):2825–2834.
   PubMed Web of Science ®Google Scholar
• Uzbekov R, Prigent C. A journey through time on the discovery of cell cycle regulation. Cells. 2022;11(4):704.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Cai J, Shi K, et al. Germacrone induces lung cancer cell apoptosis and cell cycle arrest via the Akt/MDM2/p53 signaling pathway. Mol Med Rep. 2021;23(6):452.
   PubMed Web of Science ®Google Scholar
• Su D, Wang W, Wu X, et al. Meriolin1 induces cell cycle arrest, apoptosis, autophagy and targeting the Akt/MAPKs pathways in human neuroblastoma SH-SY5Y cells. J Pharm Pharmacol. 2020;72(4):561–574.
   PubMed Web of Science ®Google Scholar
• Mounika P, Gurupadayya B, Kumar HY, et al. An overview of CDK enzyme inhibitors in cancer therapy. Curr Cancer Drug Targets. 2023;23(8):603–619.
   PubMed Web of Science ®Google Scholar
• Wu JS, Jiang J, Chen BJ, et al. Plasticity of cancer cell invasion: patterns and mechanisms. Transl Oncol. 2021;14(1):100899.
   PubMed Web of Science ®Google Scholar
• García de Herreros A, Duñach M. Intracellular signals activated by canonical Wnt ligands independent of GSK3 inhibition and β-Catenin stabilization. Cells. 2019;8(10):1148.
   PubMed Web of Science ®Google Scholar
• Liao S, Chen H, Liu M, et al. Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway. Aging. 2020;12(2):1527–1544.
   PubMedGoogle Scholar
• Chipuk JE, Mohammed JN, Gelles JD, et al. Mechanistic connections between mitochondrial biology and regulated cell death. Dev Cell. 2021;56(9):1221–1233.
   PubMed Web of Science ®Google Scholar
• Choi NR, Choi WG, Kwon MJ, et al. [6]-Gingerol induces caspase-dependent apoptosis in bladder cancer cells via MAPK and ROS signaling. Int J Med Sci. 2022;19(7):1093–1102.
   PubMed Web of Science ®Google Scholar
• Wu MF, Huang YH, Chiu LY, et al. Curcumin induces apoptosis of Chemoresistant lung cancer cells via ROS-regulated p38 MAPK phosphorylation. Int J Mol Sci. 2022;23(15):8248.
   PubMed Web of Science ®Google Scholar
• Bailly C. Regulation of PD-L1 expression on cancer cells with ROS-modulating drugs. Life Sci. 2020;246:117403.
   PubMed Web of Science ®Google Scholar
• Shi X, Chang M, Zhao M, et al. Traditional Chinese medicine compounds ameliorating glomerular diseases via autophagy: a mechanism review. Biomed Pharmacother. 2022;156:113916.
   PubMed Web of Science ®Google Scholar
• Yang Z, Zhang Q, Yu L, et al. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer. J Ethnopharmacol. 2021;264:113249.
   PubMed Web of Science ®Google Scholar
• Wu HT, Li CL, Fang ZX, et al. Induced cell cycle arrest in triple-negative breast cancer by combined treatment of itraconazole and rapamycin. Front Pharmacol. 2022;13:873131.
   PubMed Web of Science ®Google Scholar
• Lee JG, Kim JH, Ahn JH, et al. Jaceosidin, isolated from dietary mugwort (Artemisia princeps), induces G2/M cell cycle arrest by inactivating cdc25C-cdc2 via ATM-Chk1/2 activation. Food Chem Toxicol. 2013;55:214–221.
   PubMed Web of Science ®Google Scholar
• Khan M, Rasul A, Yi F, et al. Jaceosidin induces p53-dependent G2/M phase arrest in U87 glioblastoma cells. Asian Pac J Cancer Prev. 2011;12(12):3235–3238.
   PubMedGoogle Scholar